GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » Short Percentage of Float

Synmosa Biopharma (ROCO:4114) Short Percentage of Float


View and export this data going back to 2003. Start your Free Trial

What is Synmosa Biopharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Synmosa Biopharma's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Synmosa Biopharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synmosa Biopharma's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synmosa Biopharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Synmosa Biopharma's Short Percentage of Float falls into.


Synmosa Biopharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » Short Percentage of Float
Comparable Companies
TPE:3705 ROCO:6576 ROCO:6620 TPE:1720 TPE:4119 ROCO:6785 TPE:1789 TPE:4746 ROCO:4105 ROCO:4166 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 6, Gongye 1st Road, Hukou Township, Hsinchu County, Hsinchu, TWN
Website
https://www.synmosa.com.tw
Synmosa Biopharma Corp is engaged in the research and development, manufacturing, marketing, and distribution of pharmaceutical products, medical devices, cosmetics, animal drugs, chemical food additives, and beverages. It is also involved in manufacturing and sales, and environmental drugs wholesale (retail), as well as the import and export of related businesses. The company provides prescription, OTC medicines, and healthcare products under its Synmosa trademark. The reporting segments of the company are; the Generic Drugs segment which derives key revenue, and the Active Pharmaceutical Ingredients segment.

Synmosa Biopharma Headlines

No Headlines